Ozempic and Rybelsus: semaglutide for type 2 diabetes in Malta
Ozempic, Wegovy and Rybelsus all contain semaglutide, a GLP-1 receptor agonist, but they are different products with different authorised uses. Ozempic, a weekly injection, and Rybelsus, a daily tablet, are authorised for type 2 diabetes; Wegovy is authorised for weight management. All three are medicines subject to medical prescription. This page explains how the three products differ, the doses of Ozempic and Rybelsus in the product information, the side effects and what we can and cannot do.
Semaglutide: one substance, three products
Semaglutide is a GLP-1 analogue: it binds to and activates the receptor of glucagon-like peptide 1, one of the body's own hormones. The product information describes GLP-1 as a physiological regulator of appetite and calorie intake, with receptors in several areas of the brain involved in appetite.
The three products are authorised centrally for the European Union, and their product information is published by the European Medicines Agency. Ozempic is injected under the skin once a week and Rybelsus is a tablet taken once a day; Wegovy exists as a weekly injection and as a daily tablet. The products differ in strengths, in how the dose is built up and in what they are authorised for, so one is not swapped for another on your own initiative. Even the switch between the tablet and the injection cannot easily be predicted, according to the product information.
Medicines from the same or a related group are described on the tirzepatide page and the liraglutide page, and the group is compared by substance in our overview of GLP-1 medicines.
Ozempic: a weekly injection for type 2 diabetes
Ozempic is authorised for adults with type 2 diabetes that is not well enough controlled, always together with diet and exercise. It can be used on its own when metformin is not suitable, or added to other diabetes medicines, including insulin. Its safety and efficacy have not been established under 18 years.
Ozempic is not a weight loss medicine. The product information states that semaglutide reduces body weight through lower energy intake, but Ozempic is not authorised for weight management, so a request for Ozempic cannot be based on wanting to lose weight. Semaglutide for weight management is authorised as Wegovy, described in the next section. Ozempic is not intended for type 1 diabetes or for treating diabetic ketoacidosis, and semaglutide is not a substitute for insulin.
The dose steps in section 4.2 are summarised below; your own dose is set by the doctor. If a dose is missed, the product information says to inject it as soon as possible within 5 days; after more than 5 days, skip it and take the next dose on the usual day. Do not use a double dose to make up for a forgotten one, and never share your pen or needles with other people. Do not stop treatment by yourself, even when you feel better: in type 2 diabetes, stopping suddenly means losing control of blood sugar, so any change of dose or a stop is something you agree with the doctor.
| Ozempic step | Weekly dose | When |
|---|---|---|
| Starting dose (not a maintenance dose) | 0.25 mg once a week | First 4 weeks |
| Second step | 0.5 mg once a week | After 4 weeks on 0.25 mg |
| Further steps, if needed for blood sugar control | 1 mg, then 2 mg once a week | Each after at least 4 weeks on the previous dose |
| Maximum | 2 mg once a week | Higher weekly doses are not recommended |
Wegovy: semaglutide for weight management
Wegovy contains the same active substance, semaglutide, but it is a separate product authorised for weight management, with its own pens, a tablet form, its own dose steps and higher maintenance doses than Ozempic. Its authorised uses, doses and warnings are described on our page on Wegovy. One product is not used in place of the other without the doctor's decision.
Rybelsus: semaglutide as a daily tablet for type 2 diabetes
Rybelsus is semaglutide in tablet form, authorised for adults with type 2 diabetes that is not well enough controlled, together with diet and exercise, on its own when metformin is not suitable or with other diabetes medicines. It is not authorised for weight management.
Treatment starts at the lowest strength for one month and then moves to a maintenance dose, with further steps only after at least one month on the current dose; the highest daily dose is 50 mg, and only one tablet is taken a day. The tablet is swallowed whole on an empty stomach after at least 8 hours without food, with no more than half a glass of water, and you wait at least 30 minutes before eating, drinking or taking other medicines, because a shorter wait reduces absorption.
Rybelsus is described here for information, because it shares its active substance with Ozempic and Wegovy. The choice between a tablet and an injection, and the dose when switching, belong to the doctor who follows your diabetes.
How semaglutide works
Semaglutide lowers blood sugar in a glucose-dependent way: it increases the release of insulin and reduces the release of glucagon when blood sugar is high, and it causes a minor delay in the emptying of the stomach after a meal. During low blood sugar it reduces insulin release and does not impair glucagon release.
Because that action depends on blood sugar, low blood sugar is not typical when semaglutide is used on its own. The risk rises in combination with insulin or a sulfonylurea, and in those cases the doctor may lower the doses of those medicines and ask you to measure blood sugar more often.
In the brain, semaglutide acts on areas that regulate food intake. The product information describes lower energy intake, a stronger feeling of fullness and less hunger, and this is why many people eat less during treatment. The action is long-lasting, so the injection is given once a week. The effect is judged by the doctor from laboratory results and measurements over a longer period.
Side effects and when to contact a doctor
The most frequently reported side effects are digestive: nausea, diarrhoea, constipation, abdominal pain and vomiting, mainly while the dose is being raised. Indigestion, reflux, burping, wind, bloating and inflammation of the stomach lining are also described. Smaller meals, eating slowly and avoiding very fatty food help.
Headache, dizziness, tiredness, changes in taste, a faster heart rate and reactions at the injection site are also described; the Wegovy product information also lists hair loss. Gallstones are a recognised risk, so pain in the right upper abdomen is a reason to contact a doctor. Vomiting and diarrhoea can lead to dehydration, which can worsen kidney function, so drink enough and tell the doctor early.
Stop the medicine and seek medical help in the case of severe and persistent abdominal pain, especially spreading to the back and with vomiting, because acute pancreatitis is a recognised risk, or if you notice signs of an allergic reaction such as swelling of the face, lips or throat and difficulty breathing. In an emergency, call 112.
Before any procedure under general anaesthesia or deep sedation, including a gastroscopy or a colonoscopy done under sedation, tell the anaesthetist and the rest of the team that you use this medicine. Cases of pulmonary aspiration have been reported with GLP-1 receptor agonists, because food can stay in the stomach for longer than expected. Mention it for a procedure arranged at short notice just as much as for a planned one.
A change in vision during treatment is a reason to contact a doctor rather than to wait, particularly if you have diabetic eye disease: in people with diabetic retinopathy, a higher risk of complications has been observed. Sudden loss of vision, in one eye or both, calls for an urgent eye examination: it can be caused by non-arteritic anterior ischaemic optic neuropathy (NAION), reported with semaglutide. Tell the doctor looking after your treatment as well, because stopping the medicine is the doctor's decision. The full list of side effects is in the leaflet for your pack.
Pregnancy, contraception and breastfeeding
The product information recommends contraception for women who could become pregnant while using semaglutide. Semaglutide should not be used during pregnancy. If you wish to become pregnant, or become pregnant, it is stopped, and it should be stopped at least 2 months before a planned pregnancy, because it stays in the body for a long time. It should not be used while breastfeeding.
The product information states that semaglutide is not expected to make oral contraceptives less effective. Severe vomiting or diarrhoea can still make a contraceptive pill less reliable, so tell the doctor if it happens. We do not start this treatment in pregnancy, when you are planning a pregnancy or while you are breastfeeding.
Interactions, alcohol and when the medicine is not suitable
Slower stomach emptying can affect how medicines taken by mouth pass into the blood. For most medicines that has no practical meaning, but the doctor takes it into account for those with a narrow safety margin; for warfarin and related medicines, the product information recommends frequent INR checks when semaglutide is started. Bring a complete list of everything you take, including products bought without a prescription, supplements and herbal preparations.
The combination that needs most attention is insulin or a sulfonylurea at the same time, because the risk of low blood sugar is higher. It is worth recognising the signs, such as shaking, sweating, confusion and strong hunger. Semaglutide should not be combined with another GLP-1 receptor agonist.
Alcohol changes blood sugar, puts a load on the digestive system and makes worse the complaints that are most common with this treatment. In diabetes, a fall in blood sugar after alcohol can come late, often during the night.
The only contraindication in the product information is an allergy to semaglutide or to an ingredient. Before prescribing, the doctor still checks for a past inflammation of the pancreas, severe gastroparesis or other serious disease of the digestive system, gallbladder disease, advanced diabetic eye disease, severe kidney or liver disease, an eating disorder and a family history of rare thyroid and endocrine disease.
Prescription status, cover and the price at the pharmacy
Ozempic, Wegovy and Rybelsus are medicines subject to medical prescription: that is their classification in Annex II B of the EU product information. A pharmacy therefore supplies them only against a prescription, and the decision to prescribe belongs to a doctor after an assessment of your medical information.
The price of these medicines in Malta is set by the pharmacy and depends on the product, the strength and the pack, so we do not quote it, and the pharmacy is the place to ask. It is not an ePrescription and does not appear in myHealth; it is outside POYC and the Government Formulary List, and you pay for the medicine at the pharmacy in full. Our fee for the doctor's review is a separate item and never includes the medicine.
The Medicines Authority states that in Malta "all medicinal products are dispensed only from pharmacies", and no internet pharmacies have been established in Malta. Ozempic offered online outside a pharmacy may be falsified.
What happens online and what does not
Online, only the doctor's review takes place; the medicine is dispensed by a pharmacy. A request for any semaglutide product goes through our Weight Loss Treatment service, also when Ozempic is used for type 2 diabetes. For Ozempic the doctor assesses the type 2 diabetes indication you describe, and a request cannot be based on wanting to lose weight.
You fill in a medical questionnaire about the medicine, your health and other medicines you take, and the doctor reviews it in writing.
If the doctor has questions, they ask them in writing in the chat in your account, and you get an email to let you know. There is no video call, no phone call and no live chat. A first prescription is possible only where your answers and recent results show clear indications; the doctor may ask for more, recommend that you see a doctor in person, or decline. For some conditions, and in some individual cases, it is advisable to see a doctor in person; the doctor may recommend this.
If the doctor issues a prescription, you receive it as a PDF by email. You print it and bring it on paper to a pharmacy in Malta together with photo identification. Your prescription is issued in the standard EU cross-border format set out in Directive 2012/52/EU. A pharmacy in Malta may dispense it; the decision rests with the pharmacist. Take the prescription to a pharmacy within six months of the date on it; a prescription for an antibiotic cannot be dispensed more than ten days after its date of issue.
The fee covers the medical consultation, not the issuing of a document. If the doctor declines on medical or legal grounds, we refund the fee. If the doctor asks you for documents, you have at least 7 days to send them in and we send you a reminder; if you ask us, we agree a longer deadline. If the case still cannot be completed, we close the request, let you know and refund the fee in full.
Who reviews your request?
Every request is reviewed by one doctor: Damian Wojno, a doctor registered with the Polish Medical Chamber, licence no. 3211301. The doctor is not registered with the Medical Council of Malta. We do not prescribe opioids, benzodiazepines, Z-drugs, stimulants, gabapentinoids or medical cannabis. This is our own rule and goes further than the Maltese lists of controlled drugs. Semaglutide is not affected by it.
Is Ozempic prescription only in Malta?
Ozempic has a central EU authorisation, and its product information (Annex II B) classifies it as a medicine on medical prescription; the same applies to Wegovy and Rybelsus. A pharmacy supplies it only against a prescription, because the choice of medicine and dose depends on test results, other conditions and everything else you take. A review can also end in a refusal.
What is the difference between Ozempic and Wegovy?
Both contain semaglutide, but Ozempic is a weekly injection authorised for type 2 diabetes, with weekly doses up to 2 mg, while Wegovy is a separate product authorised for weight management, with its own pens, a tablet form and higher doses. One is not used in place of the other without the doctor's decision, and Wegovy has its own page on this site.
Can Ozempic be prescribed for weight loss?
The authorised use of Ozempic is type 2 diabetes, not weight loss, so a request for it cannot be based on wanting to lose weight. Semaglutide for weight management is authorised as Wegovy, and other medicines for weight management are described on the tirzepatide and liraglutide pages. The decision in every case belongs to the doctor.
What doses does Ozempic come in?
Ozempic starts at 0.25 mg once a week for 4 weeks, which is not a maintenance dose, and then goes up to 0.5 mg. If blood sugar needs better control, the dose can be raised to 1 mg and then to 2 mg, each time after at least 4 weeks on the previous dose; weekly doses above 2 mg are not recommended. Your own dose is set by the doctor.
Which side effects of Ozempic are common?
Digestive complaints are the most common: nausea, diarrhoea, constipation, abdominal pain and vomiting, mainly while the dose is being raised. Headache, dizziness, tiredness and reactions at the injection site are also described. Severe and persistent abdominal pain, a sudden loss of vision or signs of an allergic reaction are reasons to seek medical help. The full list is in the leaflet for your pack.
What is Rybelsus?
Rybelsus is semaglutide as a tablet taken once a day, authorised for adults with type 2 diabetes. It is taken on an empty stomach with a sip of water, at least 30 minutes before food, drink or other medicines, and only one tablet is taken a day. It is not authorised for weight management.
Is alcohol allowed with semaglutide?
The medicine and alcohol are not directly incompatible, but alcohol changes blood sugar and can increase the risk of it falling, especially alongside insulin or a sulfonylurea. It also irritates the digestive system, which is often more sensitive during this treatment. Discuss the amount with the doctor who is following your treatment.
Can semaglutide be prescribed online?
The doctor can review a request through our Weight Loss Treatment service, also when Ozempic is used for type 2 diabetes, but a review is not a promise of a prescription. Continuing treatment that a doctor has already started is the simpler case, while starting needs clear indications in your answers and recent results. The medicine itself is dispensed only by a pharmacy. We do not promise a deadline.
- EMA: Ozempic (semaglutide) product information, sections 4.1-4.6, 4.8, 5.1 and Annex II B
- EMA: Wegovy (semaglutide) product information, sections 4.1, 4.2, 5.1 and Annex II B
- EMA: Rybelsus (semaglutide tablets) product information, sections 4.1, 4.2 and Annex II B
- EMA: Ozempic, European public assessment report
- Medicines Authority: prescription-only and non-prescription medicines, validity of prescriptions
- Medicines Act (Cap. 458), Article 81(3) (legislation.mt)
- Prescription and Dispensing Requirements Rules (S.L. 458.49), rule 4 (legislation.mt)
- Commission Implementing Directive 2012/52/EU (EUR-Lex, English)